Immunological Escape Mechanisms in Pancreatic Carcinoma
Authors:
- 1 June 1999
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 880 (1) , 243-251
Abstract
Abstract: Malignancies have developed several strategies to evade immune surveillance. We have investigated pancreatic cancer cell lines and pancreatic cancer surgical specimens to evaluate possibilities of tumor escape in the Fas system, and local immune suppression. Despite Fas expression the majority of cell lines was resistant to Fas‐mediated apoptosis. The Fas‐associated phosphatase‐1 is a strong candidate to confer Fas resistance in pancreatic cancer cells. In addition, all investigated pancreatic cancer cell lines and cancer specimens expressed Fas ligand. Fas ligand was functional in cancer cell lines as shown by coculture assays of pancreatic cancer cell lines with Jurkat cells as targets. Additional local immune suppression was demonstrated by loss of T‐cell receptor/CD3‐zeta chain of pancreatic cancer infiltrating T‐lymphocytes. We conclude that these tumor escape mechanisms may contribute to the poor prognosis of pancreatic cancer but also represent targets for new treatment modalities.Keywords
This publication has 16 references indexed in Scilit:
- Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligandSurgery, 1999
- The host—tumor immune conflict: from immunosuppression to resistance and destructionImmunology Today, 1997
- A Computer-Aided Radiopharmaceutical Drug Design Study Using Ab Initio and Molecular Mechanics MethodsJournal of Molecular Modeling, 1997
- National Patterns of Care for Pancreatic CancerAnnals of Surgery, 1996
- Tumor Heterogeneity and Immunotherapy of CancerImmunological Reviews, 1995
- FAP-1: A Protein Tyrosine Phosphatase That Associates with FasScience, 1995
- Identification of human cancers deficient in antigen processing.Journal of Experimental Medicine, 1993
- Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4Cell, 1992
- The JAM test A simple assay for DNA fragmentation and cell deathJournal of Immunological Methods, 1991
- Inhibition of human NK cell and LAK cell cytotoxicity and differentiation by PGE2Cellular Immunology, 1989